Legence Corp.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $LGN in the last 7 days.
No SEC Form 4 filings for $LGN in the last 30 days.
See all $LGN insider activity →Tigress Financial raised its price target for Legence Corp (NASDAQ:LGN) to $130, citing AI growth, record backlog, and earnings acceleration. The stock trades at $64.91, below its fair value of $67.14. Legence reported 69% revenue growth over the past year and a 111% increase in Q2 2026, but missed earnings expectations with a loss of $0.37 per share. BTIG lowered its target to $100 due to margin concerns.
Tigress Financial raised its price target for Legence to $130 from $125, maintaining a Buy rating. The company's stock is currently at $62.78, reflecting a 5-day change of -1.38% and a year-to-date change of +46.47%.
Legence Corp. (LGN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 18, 2026, the Board of Directors (the “Board”) of Legence Corp., a Delaware corporation (the “Company”), increase
Recent LGN coverage spans earnings, financial news and corporate actions.
Positive revenue growth and strong EBITDA offset earnings miss, supporting a higher valuation.
Tigress Financial raised its price target for Legence to $130 from $125, maintaining a Buy rating. The company's stock is currently at $62.78, reflecting a 5-day change of -1.38% and a year-to-date change of +46.47%.
A routine governance update with modest potential impact via audit and nomination committee oversight, but no direct operational or financial guidance changes.
Analysts downgraded 2026 EPS after the quarterly results, even as they raised revenue estimates, keeping the consensus price target unchanged.
Raised full-year outlook plus record backlog shifts the near-term risk/reward from “losses and weak momentum” toward improving execution, despite continued net losses and margin pressure.
alphai scores every news story that mentions LGN with an AI model for sentiment and relevance, and aggregates insider trades from Legence Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Tigress Financial raised its price target for Legence Corp (NASDAQ:LGN) to $130, citing AI growth, record backlog, and earnings acceleration. The stock trades at $64.91, below its fair value of $67.14. Legence reported 69% revenue growth over the past year and a 111% increase in Q2 2026, but missed earnings expectations with a loss of $0.37 per share. BTIG lowered its target to $100 due to margin concerns.
2 min readTigress Financial raised its price target for Legence to $130 from $125, maintaining a Buy rating. The company's stock is currently at $62.78, reflecting a 5-day change of -1.38% and a year-to-date change of +46.47%.
1 min readLegence Corp. (LGN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 18, 2026, the Board of Directors (the “Board”) of Legence Corp., a Delaware corporation (the “Company”), increase
2 min readLegence Corp. (NASDAQ:LGN) shares rose 3.2% to $66.38 after quarterly results. Revenue beat expectations by 18% to $1.3b, but Legence reported a statutory loss of $0.37 per share versus analyst profit forecasts. Analysts updated 2026 consensus to $4.78b revenue and $0.89 EPS, with the price target unchanged at $103.
4 min readLegence (LGN) shares rose about 5% after its Q2 report showed revenue of US$1.26b and a record US$5.7b backlog, alongside a raised full-year outlook. The company reported a Q2 net loss of US$27.8m versus a profit a year earlier and adjusted guidance for 2026. Investors are weighing backlog strength against ongoing losses and higher capex.
4 min readLegence Corp. reported Q2 2026 results on Aug. 13, citing record revenue and backlog growth tied to data center and mission-critical building systems demand. Revenue rose to $1.262B (+111% YoY) and backlog to $5.67B (+105%). Adjusted EPS was -$0.37 vs +$0.21 expected. Shares fell over 7% to $63.68; full-year guidance was raised to $4.7B-$4.8B revenue.
7 min readLegence (building-systems contractor) reported Q2 2026 revenue of $1.262B, up 111% Y/Y, helped by the Bowers Group acquisition. Adjusted EPS was -$0.37 versus a +$0.21 consensus. Shares fell 7.29% to $63.68. The company raised FY2026 guidance to $4.7B-$4.8B revenue and $565M-$585M adjusted EBITDA.
6 min readLegence (LGN) reported Q2 2026 revenue of $1.262B, up from $599M a year earlier, and adjusted EBITDA of $155M. Adjusted EPS was -$0.37 versus a $0.21 consensus estimate. The stock fell 6.3% premarket to $64.35. Legence raised full-year 2026 revenue guidance to $4.7B-$4.8B and EBITDA to $565M-$585M.
4 min readLegence (NASDAQ:LGN) reported Q2 2026 revenue of $1.26 billion, up 110.7% year over year, and Adjusted EBITDA of $154.6 million. The company posted a net loss of $27.8 million and ended with $292 million cash and $1.03 billion debt. It raised FY2026 revenue guidance to $4.7–$4.8 billion and Adjusted EBITDA to $565–$585 million.
4 min readBernstein kept Outperform ratings on Legence (LGN, PT $103), Eaton (ETN, PT $534), Hubbell (HUBB, PT $584) and Vertiv (VRT, PT $368), and Market-Perform on Quanta Services (PWR, PT $748), citing modularization in data centers to address MEP craft labor constraints. It links labor limits to higher capacity additions and notes recent earnings and guidance updates for several firms.
7 min read
